Loading...
•
Apr 04
Enovis Q1 2025 Earnings Report
reported its financial results for the first quarter ended April 4, 2025
Key Takeaways
Enovis delivered a strong first quarter in 2025 with revenues and margins exceeding expectations, driven by continued commercial momentum and growth in both Prevention & Recovery and Reconstructive segments.
First-quarter net sales grew 8% on a reported basis and 9% on a comparable basis year-over-year.
Adjusted EBITDA was $99 million, or 17.7% of sales, a 160 basis point increase from the prior-year quarter.
Net loss from continuing operations was $56 million, or $0.98 per share.
Adjusted net earnings per diluted share were $0.81.
Enovis
Enovis
Enovis Revenue by Segment
Revenue by Segment
Prevention and Recovery Revenue
CapyFin.comReconstructive Revenue
CapyFin.com Forward Guidance
Enovis updated its full-year 2025 financial expectations, raising revenue guidance but lowering adjusted EBITDA and adjusted EPS forecasts.
Positive Outlook
- Revenue expected in the range of $2.22-2.25 billion, an increase from prior expectations.
- Continued focus on driving above-market growth.
- Strategic investment in the business.
- Multi-year cadence of high-impact product launches.
- Damien McDonald appointed as CEO effective May 12th, 2025.
Challenges Ahead
- Adjusted EBITDA forecasted at $385-395 million, lower than the prior outlook of $405-415 million.
- Adjusted EBITDA forecast includes a $20 million tariff related impact.
- Full-year adjusted earnings per share updated from $3.10-$3.25 to $2.95-$3.10.
- Navigating a complex global environment.
- Uncertainties regarding reconciling items for forward-looking GAAP measures.
Revenue & Expenses
Visualization of income flow from segment revenue to net income